Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Vergiss die Indizes - Forge steigt um 40 %, während der S&P & Dow fällt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 907048 | ISIN: FR0000035370 | Ticker-Symbol: 1DJ
Frankfurt
25.04.25
09:59 Uhr
26,400 Euro
+0,300
+1,15 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BASTIDE LE CONFORT MEDICAL SA Chart 1 Jahr
5-Tage-Chart
BASTIDE LE CONFORT MEDICAL SA 5-Tage-Chart
RealtimeGeldBriefZeit
26,60026,70011:35

Aktuelle News zur BASTIDE LE CONFORT MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19.03.BASTIDE: 2024-2025 half-year results / Recurring operating margin at 9.1%, up 80 bps / Operating FCF positive at EUR 9.4 million / Improvement in financial leverage / upward revision of recurring operating margin target to 9.1%379Caissargues, March 19, 2025 - Groupe Bastide, a leading European provider of home healthcare services, published its 2024-2025 half-year results on December 31, 2024. Groupe Bastide's 2024-2025...
► Artikel lesen
13.02.BASTIDE: Organic growth of 8.4% in first-half 2024 2025: Home healthcare services up 10.2% and Return to growth in the Homecare business / 2024-2025 targets confirmed350Caissargues, February 13, 2025 In € millions 2023-2024 published 2023-2024* Adjusted 2024-2025 published Change First-quarter revenue 127.9 122.7 133.8 +9.1% Second-quarter...
► Artikel lesen
08.01.BASTIDE obtains an extended license to operate in Canada in the Respiratory Care segment / Sale of French stomatherapy subsidiary CICA PLUS288Caissargues, January 8, 2025 - Groupe Bastide, one of Europe's leading players in home healthcare services, announces its newly extended license to operate in the field of respiratory care in British...
► Artikel lesen
14.11.24BASTIDE: Highly dynamic organic growth in Q1 2024-25 at 9.0%: 10.9% growth in home healthcare services and rebound in the homecare business, up 6.0% / Disposal of Swiss commercial business finalized and 2024-2025 targets confirmed384Caissargues, November 14, 2024 - Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-quarter 2024-2025, ending September 30, 2024. In...
► Artikel lesen
04.11.24BASTIDE: 2024-2025 financial calendar289Caissargues, November 4, 2024 Events Dates* 2024-2025 Q1 Revenue Thursday November 14, 2024 2024-2025 H1 Revenue Thursday February 13, 2025 2024-2025 H1 Results Wednesday...
► Artikel lesen
23.10.24BASTIDE: 2023-2024 annual results: Solid growth in revenue and recurring operating margin of 8.5%, exceeding the target / improved profitability and a focus on reducing debt in 2024-25300Caissargues, October 23, 2024 - Groupe Bastide, leading European provider of home healthcare services, announces its earnings for the 2023-2024 financial year ended 30 June 2024. The full-year...
► Artikel lesen
29.08.24BASTIDE: Annual revenue: EUR 530 million (up 8.2%) exceeding the target of EUR 520 million / Organic growth accelerated in fourth quarter 2023-2024: up 9.5% / Profitability target of 8.4% confirmed for 2023-2024312Caissargues, August 29, 2024 In € millions 2022-2023 published 2022-2023* restated 2023-2024 published Change Fourth-quarter revenue 127.9 122.2 134.5 +10.1% Annual...
► Artikel lesen
BASTIDE LE CONFORT MEDICAL Aktie jetzt für 0€ handeln
25.07.24BASTIDE: Financing resources reinforced through a new syndicated loan - Medium-term financing secured and debt maturity extended520Caissargues, July 25, 2024 Groupe Bastide announced today that it has set up a new financing contract for €375 million, including a syndicated loan and a revolving credit facility, as part of its...
► Artikel lesen
15.05.24BASTIDE: Organic growth accelerated in third quarter 2023-2024 up 7.5% and sale of Homecare business in Switzerland in progress475Caissargues, May 15, 2024 In € millions 2022-2023 published 2022-2023* restated 2023-2024 published Change vs. restated 3rd quarter revenue 130.7 124.5 134.7 +8.2% 9-month...
► Artikel lesen
9 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1